Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by Zibo510on Mar 16, 2024 1:01pm
43 Views
Post# 35936594

RE:RE:Full Circle

RE:RE:Full Circle I think you made a good decision to pick up cheap shares, I did as well between  .17 & .18 and got my average down to  .19

I believe they have already launched the new Biodex products and have projected a 7% increase in sales, of course they didn't state 7% of what amount. 

This management has been very careful to not mention any $ values regarding revenue or sales volumes,  they just linform us as to what the plan to turn thing's around are and the progress they are making. 

To me the most important information they released is that they have completed all aspects of the new business plan including revenue. 

Q3 revenue was 20 million, if they match that in Q4 they are on track for 80m a year, if so I wouldn't be surprised to see 90-100million this year since the Biodex products are just getting started. 

If you look at a SP based on price to sales at yearly revenue of 80 million 1 x sales gives you a SP of 1.42 and apparently peers in this industry trade at 3 to 4 x sales, one can only wish, something to think about though. 


<< Previous
Bullboard Posts
Next >>